INTERNATIONAL PATENT: MONTE ROSA THERAPEUTICS AG FILES APPLICATION FOR "COMBINATION THERAPIES COMPRISING A CDK2 DEGRADER AND A CDK4/6 INHIBITOR"

GENEVA, Nov. 3 -- MONTE ROSA THERAPEUTICS AG (Klybeckstrasse 191WKL-136.34057 Basel) filed a patent application (PCT/EP2025/061258) for "COMBINATION THERAPIES COMPRISING A CDK2 DEGRADER AND A CDK4/6 INHIBITOR" on Apr 24, 2025. With publication no. WO/2025/224262, the details related to the patent application was published on Oct 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): RITZEN, Andreas (Klybeckstrasse 191WKL-136.34057 Basel), RYCKMANS, Thomas (Klybeckstrasse 191WKL-136.34057 Basel), MCALLISTER, Laura Ann (Klybeckstrasse 191WKL-136.34057 Basel), OLEINIKOVAS, Vladimiras (Klybeckstras...